ⓘ Evinacumab

                                     

ⓘ Evinacumab

Evinacumab is a monoclonal antibody designed for the treatment of dyslipidemia.

This drug was developed by Regeneron pharmaceuticals, Inc. In phase 1, first-in-human, ascending single dose, placebo, placebo-controlled, double-blind study evaluated the safety and efficacy evinacumab subcutaneously or intravenously IV in subjects with elevated TGS 150≤ Tg ≤450 mg / l and / or LDL cholesterol ≥100 mg / DL. Evinacumab is dose-responsive decrease in the maximum decrease of Tg on the 4th day with an Average % change from baseline from -1.0% to -75.0% from low to high dose vs 9.0% for PBO IZH "P

                                     
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists:
  • Angiopoietin 3 Kinase inhibitors: Altiratinib CE - 245677 Rebastinib Antibodies: Evinacumab against angiopoietin 3 Nesvacumab against angiopoietin 2 CNTF Agonists: